- Prevent Cancer Foundation - http://preventcancer.org -

Recent Legislation and Regulatory Action

Posted By mar2 On February 23, 2012 @ 6:23 pm In | No Comments

letter [1] commending Senators Harkin and Enzi and Representatives Upton and Waxman for their efforts to develop legislation aimed at protecting the pharmaceutical distribution supply chain. Safe and effective pharmaceutical products are a vital aspect of cancer patient’s treatment, and it is of the utmost importance that these drugs are not counterfeited or tampered with. After reviewing the draft bill, the CLC has made several comments recommendations which will go far in ensuring pharmaceutical distribution security.

letter [2] to Marilyn Tavenner, Acting Administrator for the Centers for Medicare and Medicaid Services, urging her to reconsider.

letter [3] to learn more about this ruling.

letter [4] sent by the Prevent Cancer Foundation to Representatives John Barrow (GA-12) and Marsha Blackburn (TN-7) in support of the USPSTF Transparency and Accountability Act.

letter [5]urging the USPSTF to expedite review of its 2004 recommendation on lung cancer screening to improve access for high risk patients.

letter [6] to the Chairmen and Ranking Members of the subcommittee on Health urging them to support the reauthorization. PDUFA was first passed into law by Congress in 1992, with the purpose of funding the new drug approval process by allowing the FDA to collect fees from drug manufacturers. These funds allow the FDA to review, and therefore approve, new drugs in a much more expeditious manner; since the introduction of PDUFA, the average approval time for non-priority new drugs has dropped from 27 to 14 months. Decreasing the wait time for new drugs to become available is beneficial to both patients and drug manufacturers; if PDUFA lapses, the FDA would be forced to cut many of its drug reviewers, thereby greatly increasing the wait time in the drug approval process.

Essential Health Benefits Bulletin [7], with the purpose of providing information and soliciting comments on the regulatory approach that it plans to propose to define essential health benefits (EHB) under section 1302 of the Affordable Care Act. After careful consideration, the Cancer Leadership Council (CLC), a coalition to which the Prevent Cancer Foundation belongs, compiled a list of comments for the HHS’s consideration. To read its response letter, click here. [8]

Centers for Medicare & Medicaid Services [9] and the Center for Consumer Information and Insurance Oversight [10].

here [11].

resolution [12] spearheaded by Senators Sherrod Brown, Jerry Moran and John Kerry. We urge you to contact your US Senators and ask them to cosponsor this resolution. You can join our Advocacy Action Center [13] today to communicate your support  for this resolution, and honor the more than 12,000,000 survivors of cancer alive today because of the nation’s commitment to cancer research and advances in prevention, detection, diagnosis and treatment.

View the letter [14] sent by the Prevent Cancer Foundation to Representatives Maloney and Dent endorsing the Tanning Bed Cancer Control Act of 2011.

here [15] to see how your state is doing in protecting or improving access to colorectal cancer screening and for ideas about how you can get involved.

here [16].

To read about past legislation and regulatory actions that the Prevent Cancer Foundation has been involved with, please click here [17].


Article printed from Prevent Cancer Foundation: http://preventcancer.org

URL to article: http://preventcancer.org/take-action/advocate/legislation/recent/

URLs in this post:

[1] letter: http://preventcancer.org/wp-content/uploads/2012/12/Cancer-Leadership-Council-on-drug-distribution-security-draft-November-2-.pdf

[2] letter: http://preventcancer.org/wp-content/uploads/2012/12/Cancer-Leadership-Council-Comments-on-CY-2013-physician-fee-schedule-CMS-1590-P.pdf

[3] letter: http://preventcancer.org/wp-content/uploads/2012/11/CLIA-NPRM-Support-Letter-with-Signatures-Final-minus-individuals-2.pdf

[4] letter: http://preventcancer.org/wp-content/uploads/2012/07/HR-5998-support-letter.pdf

[5] letter : http://preventcancer.org/wp-content/uploads/2012/02/HHS-USPSTF-Letter-5_3_12.pdf

[6] letter: http://preventcancer.org/wp-content/uploads/2012/04/PDUFA-final-House.pdf

[7] Essential Health Benefits Bulletin: http://cciio.cms.gov/resources/files/Files2/12162011/essential_health_benefits_bulletin.pdf

[8] here.: http://preventcancer.org/wp-content/uploads/2011/02/Cancer-Leadership-Comments-on-Essential-Health-Benefits-Bulletin-January-31-2012.pdf

[9] Centers for Medicare & Medicaid Services: http://preventcancer.org/wp-content/uploads/2011/02/Clinical_Trials_Letter_to_Marilyn-Tavenner_FINAL.pdf

[10] Center for Consumer Information and Insurance Oversight: http://preventcancer.org/Documents%20and%20Settings/Meghan.Keane/Desktop/Clinical_Trials_Letter_to_Steve_Larsen_FINAL.pdf

[11] here: http://preventcancer.org/wp-content/uploads/2011/02/HR-1394-S-752-endorsement-letter-2.pdf

[12] resolution: http://preventcancer.org/wp-content/uploads/2011/02/Congressional-Resolution-40th-Anniversary1.pdf

[13] Advocacy Action Center: http://preventcancer.org/take-action/advocate/advocacy-action-center/

[14] View the letter: http://preventcancer.org/wp-content/uploads/2011/02/HR-1676-endorsement-letter1.doc

[15] here: http://preventcancer.org/wp-content/uploads/2012/02/FINAL-2012-Report-Card.pdf

[16] here: http://preventcancer.org/files/advocate/script.pdf

[17] here: http://preventcancer.org/take-action/advocate/legislation/past-legislation-and-regulatory-action/

Copyright © 2011 PCF Dev. All rights reserved.